Form 4: Organon & Co. Executive Vittorio Nisita Reports Stock Transactions
SEC Form 4 Filing
Vittorio Nisita, Head of Global Business Services at Organon & Co., reports the vesting and subsequent sale of restricted stock units on March 31, 2024.
Summary
- On March 31, 2024, Vittorio Nisita, Head of Global Business Services at Organon & Co., engaged in transactions involving Organon common stock.
- These transactions included the vesting of 2,863 and 4,606 restricted stock units (RSUs).
- Following the vesting, shares were sold to cover tax obligations, with 981 shares sold at $18.8 and 1,578 shares sold at $18.8.
- After these transactions, Nisita directly owns 21,019 shares of common stock and 9,212 restricted stock units.
- The transactions were reported on Form 4, filed with the SEC on April 03, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax-related sales.
Key Dates
| Date | Description |
|---|---|
| 03/31/2023 | Date RSUs were granted to the Reporting Person. |
| 03/31/2024 | Date of the reported transactions, including vesting of RSUs and sale of shares. |
| 03/31/2025 | Date when remaining RSUs from the first grant will vest. |
| 03/31/2026 | Date when remaining RSUs from the second grant will vest. |
| 04/03/2024 | Date the Form 4 was signed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.